Skip to main content

stock

EXEL · EXELIXIS, INC.

What EXELIXIS, INC. reports to the SEC, read from its filings.

Open in the app

Price

The live EXEL price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on EXEL.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
247,781,692 as of 2026-07-27 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
39.9%
Net
35.3%

Returns

ROE
46.7%
ROA
34.5%

Health

Current ratio
3.5x
Debt/equity
—

Deep value

NCAV
$600.35M
NCAV per share
$2.42
Price/NCAV
Locked
NNWC
-$354.66M
NNWC per share
-$1.43
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-07-03; balance sheet at 2026-07-03.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profitOperating incomeNet incomeFiling
2026-07-03$628.69M—$248.41M$212.05M
10-Q filed 2026-08-05
2026-04-03$610.81M—$251.34M$210.47M
10-Q filed 2026-05-05
2026-01-02$598.66M—$235.22M$244.56M
DEF 14A filed 2026-04-15
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2025-10-03$597.75M—$236.54M$193.58M
10-Q filed 2025-11-04
2025-07-04$568.26M—$213.58M$184.85M
10-Q filed 2026-08-05
2025-04-04$555.45M—$186.86M$159.62M
10-Q filed 2026-05-05
2025-01-03$566.75M—$163.21M$139.89M
DEF 14A filed 2026-04-15
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2024-09-27$539.54M—$136.07M$117.97M
10-Q filed 2025-11-04
Assets
$2.49B
Equity
$1.84B

Balance as of 2026-07-03.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2026-01-02$2.32B$872.19M$782.60M$875.84M
2025-01-03$2.17B$604.62M$521.30M$671.54M
2023-12-29$1.83B$170.88M$207.80M$292.86M
2022-12-30$1.61B$201.48M$182.30M$334.91M
2021-12-31$1.43B$286.67M$231.10M$346.58M
2021-01-01$987.54M$110.06M$111.78M$178.64M
2020-01-03$967.77M$369.47M$321.01M$514.12M
2018-12-28$853.83M$438.86M$690.07M$382.42M
2017-12-29$452.48M$165.91M$154.23M$144.47M
2016-12-31$191.45M-$28.12M-$70.22M$204.59M

Company filings

events

  • Other event

    Other event
    Sep 118-K
  • Other event

    Other event
    Aug 318-K
  • Results

    Results
    Aug 58-K
  • Executive or director change, Shareholder vote results

    Executive or director changeShareholder vote results
    May 298-K
  • Results, Other event

    ResultsOther event
    May 58-K
  • Results

    Results
    Feb 108-K

5% owners ()

Insiders, politicians and funds

Insider trades, last 90 days

  • Beckerle Mary C

    Director

    Sale$526,512

    Aug 12, 7:34 PM ET

All insider trades for EXEL

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

All funds

News

Stories that named EXEL, and the market events around them.

Sign in to see this

Board

Recent signals

Signals open up here once a member has posted about EXEL.

Signals are informational.

Posts · 0

No posts yet.

Be the first to say something about EXEL.

nakagai

Signals on EXEL come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the EXEL board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

EXELIXIS, INC. (EXEL): SEC filings, financials and insider trades · Nakagai